Study Showed High Accuracy in Determining Amyloid Burden Across All Stages of Alzheimer’s Disease Progression, Supporting Early Detection, Treatment, Interventions and Tracking ALZpath pTau217 Antibody Has Now Been Utilized in Over 40 Cohort Studies with 50,000 Samples CARLSBAD, Calif.,…